Pricing Log in Create free account

ImageneBio, Inc. (IMA) vs Mereo BioPharma Group plc - Sponsored ADR (MREO)

ImageneBio, Inc. and Mereo BioPharma Group plc - Sponsored ADR are both Biotechnology companies. ImageneBio, Inc. and Mereo BioPharma Group plc - Sponsored ADR are of similar size ($47.3M and $44.8M). Across the 10 metrics below, ImageneBio, Inc. leads on 6 and Mereo BioPharma Group plc - Sponsored ADR on 4.

Valuation

Metric IMA MREO Biotechnology median
P/E n/m n/m 10.60
P/S 10.81 n/m 9.40
P/B 0.47 1.57 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.71 n/m 9.02
Earnings yield (136.60%) (62.36%) (32.88%)
Free cash flow yield (77.70%) (57.04%) (23.13%)

Profitability

Metric IMA MREO Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (41.34%) (67.85%) (51.96%)
Return on assets (38.34%) (57.73%) (46.06%)
Return on invested capital (622.37%) 0.00% 0.00%

Growth

Metric IMA MREO Biotechnology median
Revenue growth (TTM) (67.95%) — 6.76%
EPS growth (last fiscal year) 56.38% 10.16% 29.88%
Revenue growth, 5-year CAGR (38.64%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMA MREO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 21.47 5.88 4.97
Net debt to EBITDA 2.85 1.04 1.01

Dividend

Metric IMA MREO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMA MREO Biotechnology median
Market cap 47.28m 44.76m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack